Cargando…

The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review

Anaemia is a common consequence of chronic kidney disease (CKD); however, the risk factors for its development and its impact on outcomes have not been well synthesised. Therefore, we undertook a systematic review to fully characterise the risk factors associated with the presence of anaemia in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palaka, Eirini, Grandy, Susan, van Haalen, Heleen, McEwan, Phil, Darlington, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349626/ https://www.ncbi.nlm.nih.gov/pubmed/32665863 http://dx.doi.org/10.1155/2020/7692376

Ejemplares similares

Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
por: Darlington, Oliver, et al.
Publicado: (2021)

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
por: Sugrue, Daniel M., et al.
Publicado: (2019)

Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: cross sectional analysis of real-world data
por: van Haalen, Heleen, et al.
Publicado: (2020)

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
por: Linde, Cecilia, et al.
Publicado: (2019)

Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey
por: Grandy, Susan, et al.
Publicado: (2022)

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
por: Furuland, Hans, et al.
Publicado: (2018)

Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China
por: Hao, Chuan-Ming, et al.
Publicado: (2021)

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease
por: Evans, Marc, et al.
Publicado: (2019)

Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study
por: Lamerato, Lois, et al.
Publicado: (2022)

Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden
por: Kim, Kun, et al.
Publicado: (2022)

Management of anaemia in CKD—the relative importance of erythropoietin and iron
por: Agarwal, Rajiv
Publicado: (2011)

Key insights into present and future treatments of anaemia in CKD patients
por: de Francisco, Angel L. M.
Publicado: (2009)

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan
por: Matsumoto, Tetsuya, et al.
Publicado: (2021)

A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia
por: Mercadal, Lucile, et al.
Publicado: (2014)

The Incidence of Anæmia in Infancy
por: Laidlaw, Stuart
Publicado: (1931)

Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
por: Chung, Edmund Y.M., et al.
Publicado: (2021)

The Impact of Pediatric CKD on Educational and Employment Outcomes
por: Harshman, Lyndsay A., et al.
Publicado: (2023)

Correction: A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia
Publicado: (2014)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study
por: Zhang, Jianzhen, et al.
Publicado: (2023)

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis
por: McEwan, Phil, et al.
Publicado: (2022)

Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data
por: van Haalen, Heleen, et al.
Publicado: (2020)

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review
por: Pergola, Pablo E., et al.
Publicado: (2019)

Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia
por: Eriksson, Daniel, et al.
Publicado: (2016)

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
por: Locatelli, Francesco, et al.
Publicado: (2023)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

Serum uric acid and the incidence of CKD and hypertension
por: Kuriyama, Satoru, et al.
Publicado: (2015)

Plasma Biomarkers as Risk Factors for Incident CKD
por: Sarnak, Mark J., et al.
Publicado: (2022)

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
por: McEwan, Phil, et al.
Publicado: (2020)

Contemporary outcomes of anemia in US patients with chronic kidney disease
por: Wittbrodt, Eric T, et al.
Publicado: (2021)

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
por: Bennett, Hayley, et al.
Publicado: (2019)

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD
por: Morton, Rachael L., et al.
Publicado: (2016)

Reducing aggression and improving offending outcomes in youth with conduct disorder, results of a systematic review
por: McEwan, Craig, et al.
Publicado: (2021)

Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2023)

Association of Educational Attainment With Incidence of CKD in Young Adults
por: Tripathy, Swetapadma, et al.
Publicado: (2020)

Prediction of Incident Heart Failure in CKD: The CRIC Study
por: Zelnick, Leila R., et al.
Publicado: (2022)

Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
por: Obi, Yoshitsugu, et al.
Publicado: (2020)

Impact of CKD on Household Income
por: Morton, Rachael L., et al.
Publicado: (2017)

Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
por: Strain, W. David, et al.
Publicado: (2019)

Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes
por: Gordon, Jason, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v7isdtp9u5peog6vmjnpl5i3fc